
Loading, please wait...

Loading, please wait...

Amyotrophic lateral sclerosis presents complex neurodegenerative patterns that involve both upper and lower motor pathways. Clinicians frequently observe increased resting muscle activity when assessing patients during baseline neurophysiological testing. However, the diagnostic and pathophysiological relevance of this phenomenon has remained incompletely understood. A landmark study published in the Journal of Neurology provides crucial evidence demonstrating that involuntary electromyographic discharges occur nearly four times more frequently in individuals with amyotrophic lateral sclerosis than in diagnostic controls.
Patients with amyotrophic lateral sclerosis frequently struggle to maintain complete muscular relaxation during clinical and electrophysiological assessments. Consequently, baseline electromyographic silence remains elusive during standardized diagnostic protocols. This persistence of spontaneous discharges suggests extensive network disinhibition within the corticospinal axis. Previously, investigators often dismissed these baseline contractions as patient anxiety or accidental movement. However, current empirical evidence demonstrates that this neuromuscular phenomenon reflects true motor pathway pathology rather than procedural artifact.
Furthermore, quantitative assessments demonstrate marked differences between confirmed motor neuron disease cohorts and neurological mimic disorders. In clinical environments, distinguishing primary motor neurodegeneration from peripheral neuropathies, radiculopathies, or functional disorders presents major diagnostic hurdles. The quantifiable increase in resting electromyographic activity offers a reproducible objective parameter. Therefore, neurophysiologists can now leverage these continuous baseline micro-contractions to support earlier clinical stratification and enhance diagnostic confidence.
Researchers conducted a rigorous retrospective evaluation examining consecutive patients evaluated for suspected motor neuron degeneration at Aarhus University Hospital. The experimental protocol utilized standardized threshold-tracking paired-pulse transcranial magnetic stimulation targeting the first dorsal interosseous muscle. Importantly, automated software protocols systematically rejected stimulation attempts whenever the baseline electromyographic trace exceeded 30 microvolts at least five times across the 300-millisecond window immediately preceding the magnetic pulse.
Through this objective rejection metric, clinicians measured involuntary muscular tone without subjective examiner bias. The study compared seventy confirmed patients diagnosed under the Gold Coast criteria against seventy-three patient controls presenting with alternate neurological disorders. Consequently, statistical analysis revealed an adjusted estimate of 27.28 rejected stimulation trials in the motor neuron disease cohort compared to merely 7.28 rejections in control subjects. This immense disparity underscores how profound involuntary discharges compromise motor rest.
Subgroup analyses revealed crucial correlations between high rejection counts and clear upper motor neuron pathology. Specifically, patients displaying overt pyramidal features exhibited twice as many rejected stimulation attempts as those presenting exclusively with lower motor neuron phenotypes. Median rejection rates reached 40 attempts in subjects with prominent corticospinal involvement, whereas patients without upper motor neuron signs recorded a median of 20 rejections. Thus, descending inhibitory failure directly amplifies baseline motor tone.
Moreover, investigators observed robust statistical correlations between rejected stimulations and definitive bedside markers of hyperreflexia. Elevated baseline activity correlated positively with hyperactive jaw jerks and pathologically brisk biceps reflexes. As descending corticospinal fibers degenerate, spinal interneurons lose crucial glycinergic and GABAergic inhibitory modulation. As a result, anterior horn cells display marked hyperexcitability, precipitating continuous involuntary discharges. These clinical associations confirm that cortical disinhibition plays a central driving role in muscular restlessness.
Beyond clinical reflexes, researchers evaluated quantitative needle electromyography parameters to decipher underlying motor unit behavior. The rate of discarded magnetic stimulation sweeps correlated significantly with the frequency of fasciculation potentials recorded in affected limb muscles. Fasciculations represent spontaneous firing of unstable motor units, frequently originating from distal axonal arborizations or hyperexcitable motoneuronal somata. Hence, elevated baseline discharge reflects systemic physiological instability across the entire motor unit hierarchy.
Additionally, cortical excitability metrics reinforce this pathogenic link. Cortical hyperexcitability consistently represents an early pathophysiological hallmark of motor neuron degeneration. When descending excitatory volleys barrage denervated, hypersensitive spinal pools, muscle fibers fail to achieve quiescent baselines. Consequently, the combination of cortical disinhibition and peripheral axonal irritability generates persistent background electromyographic activity. This synergistic interaction provides comprehensive insight into the complex pathophysiological continuum linking the motor cortex to peripheral effectors.
These findings provide concrete, actionable guidance for neurophysiology laboratories evaluating suspected neurodegenerative conditions. Clinicians often encounter technical frustration when baseline muscle activity interferes with motor evoked potential testing. Rather than dismissing frequent automated software rejections as procedural noise, electrodiagnosticians should recognize high rejection frequencies as a potential biomarker of upper motor neuron disinhibition. This recognition proves particularly valuable in early disease stages before classic pyramidal signs manifest physically.
Furthermore, standardizing resting electromyographic activity rejection rates could enhance clinical trial stratification. Tracking motor unit disinhibition quantitatively may serve as a functional surrogate marker for therapies targeting excitotoxicity or neuroprotective pathways. As clinical neurophysiology adopts automated tracking algorithms, measuring motor quiescence provides an objective, reproducible metric. Clinicians can integrate this parameter alongside traditional needle examinations, ultimately refining diagnostic accuracy and expediting comprehensive patient care pathways.
Increased baseline muscle activity arises from progressive upper motor neuron degeneration, which impairs descending inhibitory controls. Simultaneously, unstable lower motor units fire spontaneously as fasciculations. This combined loss of central inhibition and peripheral axonal hypersensitivity prevents muscles from achieving complete electromyographic silence during intended physical rest.
Standardized threshold-tracking software continuously monitors baseline electromyographic signals prior to delivery. If the recording electrode registers electrical activity exceeding thirty microvolts at least five times within the three hundred milliseconds preceding the magnetic pulse, the automated program aborts and rejects the stimulation attempt.
Yes, quantitative baseline rejection rates show robust diagnostic separation. Patients with amyotrophic lateral sclerosis trigger nearly four times as many automated software rejections as patients with non-ALS neurological mimics, reflecting marked corticospinal disinhibition that rarely occurs in peripheral neuropathies or functional movement disorders.
Disclaimer: This content is for informational and educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Jacobsen AB et al. Increased resting muscle activity in amyotrophic lateral sclerosis. J Neurol. 2026 Nov 18. doi: 10.1007/s00415-026-14243-9. PMID: 43049901.
Vucic S, Kiernan MC. Corticomotoneuronal excitability and the diagnosis of amyotrophic lateral sclerosis. Brain. 2006;129(8):2094-2108.
de Carvalho M, Swash M. Fasciculation potentials and earliest changes in motor units in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2013;84(9):963-968.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A recent neurophysiological study reveals that ALS patients exhibit significantly elevated resting muscle activity during transcranial magnetic stimulation, strongly correlating with upper motor neuron dysfunction and fasciculation potentials, offering new insights into motor system pathophysiology.
Today

A Bayesian component network meta-analysis of 130 RCTs reveals that self-monitoring and gamification provide the clearest positive effects in mHealth physical activity interventions, while social comparison may have adverse psychological trade-offs.
Today

The GESS-AEEM consensus establishes a clear clinical implementation framework for testosterone therapy in postmenopausal women with hypoactive sexual desire disorder, focusing on transdermal dosing, precise laboratory monitoring, and safety communication.
Today

A multicenter observational study evaluated an 8-week digital health monitoring platform using wearable sensors in ambulatory heart failure. While participants achieved high daily wear-time of 11.7 hours and 80% completion, initial recruitment revealed significant technology-related onboarding barriers.
Today

A paired cadaveric study compared triple and quintuple percutaneous Achilles tendon lengthening. While quintuple hemisection showed numerically greater elongation, differences were not statistically significant.
Yesterday

A clinical decision-support framework using health checkup data from 231,683 adults predicts incident obesity with high discrimination (AUROC 0.918). The system integrates temporal survival analysis and risk-factor explanations to prioritize individualized preventive interventions.
Today